Please assess the completion status of the following clinical trial:

Trial Title: Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and females~2. Age 18 years or greater~3. Scheduled to undergo liver biopsy with ultrasound guidance at a performance site~Exclusion Criteria:~1. Liver biopsy is not intended to obtain tissue from a specific lesion~2. Known or suspected cardiac shunt~3. History of hypersensitivity to any active or inactive ingredients in Lumason

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- biopsy with Lumason (Type: EXPERIMENTAL): liver biopsy performed with prior contrast enhancement with Lumason 60.7Mg Powder for Injection (experimental method)
- biopsy with placebos (Type: PLACEBO_COMPARATOR): liver biopsy performed without prior contrast enhancement (standard method)

Based on this trial design, predict the completion outcome and termination type (if applicable).